分享两篇SCI发表的经历

分享两篇SCI发表的经历
分享两篇SCI发表的经历

分享两篇SCI发表的经历

三年前对于我来说SCI就是天书一样,在我踏进博士的门槛后我以为自己进入了地狱,也纠结也彷徨,整天刷虫友们对于博士、SCI的帖子,我选择了虫友们鼓励的那一部分来激励自己继续前行。我告诉自己坚持就是胜利,当然那是积极的坚持。在好几月之前就有这个想法,今天早上收到第二篇的接收通知后,我便想今天一定要在小木虫上谢谢那些给予我帮助的虫友们。

话不多说,我把自己这两篇投稿的经历与大家共享,希望能给大家带来一点点用处。

第一篇发表在Fitoterapia

Cover letter

Dear Editor Verotta:

We would like to submit the manuscript entitled "××××××题目" by ××××××所有作者姓名which we wish to be considered for publication in Journal of Fitoterapia.

All authors have read and approved this version of the article, and due care has been taken to ensure the integrity of the work. Neither the entire paper nor any part of its content has been published or has been accepted elsewhere. It is not being submitted to any other journal.?

We believe the paper may be of particular interest to the readers of your journal as it is the first time of ××××××研究的精华所在

Thank you very much for your reconsidering our revised manuscript for potential publication in Fitoterapia. We are looking forward to hearing from you soon. Correspondence should be addressed to Jinhui Yu at the following address, phone and fax number, and email address.

地址、学院、学校名称

Phone: + 86××××××

Fax number: + 86571××××××

Email address: ××××××@

Best wishes for you and your family!

Sincerely yours,

×××所有作者

Response to reviewers

Dear Editor:

Thank you very much for your letter and the comments from the referees about our paper submitted to Journal of Fitoterapia (FITOTE-D-11-01071). The manuscript entitled "××××××" by ××××××所有作者 have been revised according to the reviewers’ comments, and we wish i t to be reconsidered for publication in Journal of Fitoterapia.

A list of changes and responses to reviewers are as follows.

List of Actions

LOA1: The key words were changed in page.

LOA2: The name and location of the local biochemistry company have been added in section (page 3).

LOA3: A paragraph has been added in section (page 5) to further explain the determination of the cis and trans configuration of double bonds in polyprenols.

LOA4: The language was improved by English language editing of Elsevier webshop.

To Reviewer 1#,

Thank you very much for pointing out the problems in our manuscript. We have revised it according to your recommendations. We would like to know if there are still somewhere need to be amended.?

(1) Keywords: general terms should be avoided; I would change some of the keywords (homologues, identification, quantification)

The key words have been changed as follows: ××××××修改后关键词

(2) In paragraph the "local biochemistry company" should be identified by name and location.

The name and location of the local biochemistry company have been added in section (page 3). NaOH,Pyrogallol,anhydrous Na2SO4 were purchased from Hangzhou ChangqingHuagong CO., LTD.

(3) How the cis and trans configuration of double bonds in ×××××× were determined Authors should say something about.

The following paragraph has been added in section (page 5) to further explain the determination of the cis and trans configuration of double bonds in ××××××.

(4) Language should be checked for clarity and correctness.

The language was improved by English language editing of Elsevier webshop.

To Reviewer 2#,

Thank you very much for your recommendation on our paper and we have improved by English language editing of Elsevier webshop.?

All in all, thank you very much for your reconsidering our revised manuscript for potential publication in Fitoterapia. I'm looking forward to hearing from you soon. Correspondence should be addressed to ****第一作者或通讯作者at the following address, phone and fax number, and email address.

地址

Phone: + 86571××××××

Fax number: + ××××××

Email address: ××××××@

Best wishes for you and your family!

Sincerely yours,

××××××所有作者

总的来说,第一篇文章没有费很大劲。投稿后二个月左右便有消息,小修后提交,第二天便接收了!那是因为这篇文章是历经磨难后的,之前投了Separationofscience和JPBA,其中第一个期刊当天就给我回复了,那肯定是悲剧的!编辑所谓的与该期刊不符,但我认为主要是因为文章写的太垃圾,那是我第一次写SCI而且是没有任何人指点的情况下,可想而知会有多烂。随后这篇文章放了将近一年,填补了写数据,又投了第二个期刊,编辑委婉的拒了但给我修改重投的机会。我按照审稿人的意见和建议修改了几个月后重投(补数据,重新整结构框架,仅次于重写),结果悲剧了。而且不是因为修改的问题,而是说我的文章档次太低,不足以在JPBA上发表,我当时晕倒怎么不早说,害我这么长时间的重修。不过现在想想若不是重修在下次的投稿中又怎能如此顺利呢所以说所有的努力都不是白费的!

第二篇投了Journal of Ethnopharmacology,相比第一篇这个稍有磨难。也是差不多两个月的样子收到修改意见,修改后提交一直不见动静,等两个月左右的时候我有点hold不住了,编发了一封催稿信,之前看论坛里说忌讳催稿,但也看期刊吧,Journal of Ethnopharmacology的编辑第二天便给了修改建议(还是要修改),原因是第一次修改是一个审稿人的,由于另外一个审稿人一直没给才拖到第二次。也没办法,只能再改!这次相对比较快点,每到一个月便通知接收了。

Journal of Ethnopharmacology与别的期刊不同,有一份Author_checklist。不算重要但还是给大家附上附件吧(黏贴好像乱掉了),我之前也是请教的虫友。需要提醒的是初次提交和修改后要注意最后一项打勾。

Dear editor,

We would like to submit the manuscript entitled " ××××××" by ×××××× which we wish to be considered for publication in Journal

of Ethnopharmacology.

All authors have read and approved this version of the article, and due care has been taken to ensure the integrity of the work. Neither the entire paper nor any part of its content has been published or has been accepted elsewhere. It is not being submitted to any other journal.?

We believe the paper may be of particular interest to the readers of your journal as it is the first time of investigating ××××××Correspondence should be addressed to Jinhui Yu at the following address, phone and fax number, and email address.

地址

Phone: + 86××××××

Fax number: + 86571××××××

Email address: ××××××@

Thank you very much for your considering our manuscript for potential publication. I'm looking forward to hearing from you soon.

Best wishes for you and your family!

Sincerely yours,

××××××

大同小异?

单独提交revisionnotes

第一次修改

A list of changes and responses to reviewers are as follows.

List of Actions

LOA1: The reference on the selection of doses has been adapted in section (page 5).

LOA2: The details of HPLC data were supplemented in section (page 4). LOA3: Figure 3, figure 4 and figure 5 have been redrawn.?

Replies to the remarks of the reviewer 1:

The authors appreciate valuable suggestions and comments from the anonymous reviewers. We have revised our manuscript accordingly. Hope it is satisfactory now.

(1) How the doses have been selected If the doses have been adapted from

a previous publication please cite the paper.?

The doses were selected according to previous studies of ××××××。We have adapted the paper in our revised manuscript.?

(2) It would be more interesting if the authors could show the details of HPLC data in this manuscript. Which fraction has been used to perform experiments

We have provided the HPLC chromatogram of ×××××× used in the animal experiment. The fraction of the purified extract mostly consisted of ××××××, which accounting for %, %, %, %, %, %, %, %, %, %, %, respectively. The purity of the ×××××× was assessed using HPLC, amounting to > 85%.?

(3) Fig 3 and 5 should be redone. Photos may take by using little more higher objectives like 32X or 40 X to show the picture clearly. Scale bars should be mentioned inside the figure (in right corner).

We redrew the both figures. Scale bars have been mentioned inside the figure 3, figure 4 and figure 5. The magnif ication of 200× was adopted for figure 3 and figure 5, referring to many previous studies (Gui et al., 2006; Hsieh et al., 2011; Jung et al., 2012; Xiao et al., 2012). The reviewer's concern about the insufficiently clear figures might result from the low resolution of the picture in our previous version. Corresponding pictures with improved resolution were provided, which appear much clearer. We can also provide original figures if it is necessary.

References:

Gui, ., Wei, W., Wang, H., Wu, L., Sun, ., Chen, . and Wu, ., 2006. Effects and mechanisms of crude astragalosides fraction on liver fibrosis in rats. Journal of Ethnopharmacology 103: 154-159.

Hsieh, ., Liu, . and Lin, ., 2011. Anti-inflammatory properties of Ajuga bracteosa in vivo and in vitro study and their effects on mouse model of liver fibrosis. Journal of Ethnopharmacology 135: 116-125.

Jung, ., Jung, ., Son, ., Lee, ., Kang, ., Kim, . and Park, ., 2012. Inhibitory effects of the root extract of Dipsacus asperoides . Cheng et al on collagen-induced arthritis in mice. Journal of Ethnopharmacology 139: 98-103.

Xiao, J., Liong, ., Ching, ., Chang, ., So, ., Fung, . and Tipoe, ., 2012. Lycium barbarum polysaccharides protect mice liver from carbon tetrachloride-induced oxidative stress and necroinflammation. Journal of Ethnopharmacology 139: 462-470.

Yu, J., Wang, Y., Qian, H., Zhao, Y., Liu, B. and Fu, C. Polyprenols from the needles of Taxus chinensis var. mairei. Fitoterapia, in revison.

第二次修改

A list of changes and responses to reviewers are as follows.

List of Actions

LOA1: The description of the effect of TPs (protective rather than therapeutic) in the article was corrected to avoid misunderstanding.? Introduction, the last sentence (paragraph 3).

Section , “Rats treated with TPs” was changed as “Rats treated with both TPs and CCl4” (line 3)

Section , “in the livers of chronic CCl4 treated rats” was deleted by

adding “In the treatment with TPs+CCl4” at the head of the sentence. (line 7)

Discussion, the first and the last sentence (paragraph 1). Discussion, “the treatment with TPs” was changed as “the treatment with TPs+CCl4”(paragraph 2, line 9)

Discussion, the last sentence (paragraph 4)

Discussion, the last sentence (paragraph 5)

Discussion, the first sentence (paragraph 7)

LOA2: The figures and tables are explained in order in the main text.? Section , Fig. 3A (line 6) was added.

Section , Fig. 4A (line 2), Fig. 4B-C (line 3) and Fig. 4B (line 9) and Fig. 4A-B (line 10) were deleted.

Section , Fig. 5A, F (line 3), Fig. 5C-E, F (line 5) were added.? LOA3: Figure 2 was supplemented with the standard chromatogram and concrete information about the peaks under the figure.?

LOA4: The petroleum was corrected into petroleum ether.

LOA5: The discussion section was modified.

Replies to the remarks of the reviewer 2:

The authors appreciate valuable suggestions and comments from the anonymous reviewers. We have revised our manuscript accordingly.

1. Fig 6 shows that ×××××× on RNA expression is not dose dependent, rather different doses of ×××××× has op posite effect ( Fig 6 A, E,K), means that protein level of this gene could provide the missing links. According to me protein level along with RNA level could provide an insight to the mechanism of ××××××.

? ? ? ? We agree with this point. We have actually tried quantitative analyses of relative proteins to further clarify mechanism, as well as Western-Blot experiments. These efforts, however, failed due to the

technical difficulty of removing the lipid composition which seriously interfere the accuracy of protein quantification. After the optimization and improvement of the extraction for quite a long time, the experimental result was still not satisfactory. However, we believe our present results could fairly although not perfectly support our main conclusions. Anyway, we changed several interpretations of the present results to adequately discuss the mechanisms of ××××××。

2. In the conclusion, the authors claimed that " the possible mechanism involves an anti oxidative ability...". According to the Table 4 data, it is evident that lipid peroxidation of ×××××× 120 and 300 are same ( insignificantly different) but corresponding antioxidant enzyme activities were significantly differ between them.

? ? ? ? The inconsistent results between antioxidant enzyme activities and lipid peroxidation might need some explanation. As we know, the composition of the lipid peroxidation which includes many other components (Loidl-Stahlhofen and Spiteller, 1994) except malondialdehyde might have been changed under ×××××× 300 tr eatment. Moreover, the antioxidant mechanism of different drugs in various organisms is completed according to previous studies (Galano et al., 2009; Qian et al., 2011). We just speculate that the anti-fibrotic effect might be related with the antioxidant ability of the ×××××× based on the data, while the preliminary conclusion needs further experimental verifications. We have made corresponding modification on the conclusion in our manuscript.?

3. I am confused with the duration of ×××××× in animals. Induc tion of cirrhosis was done by subcutaneous injection of CCl4 for 8weeks. Simultaneous administration of drug was performed for 8weeks. Can I assume that the action of drug is to prevent the induction of cirrhosis rather than therapeutic effect

The experiment only verified the preventive effect rather than the

therapeutic effect. We will consider the therapeutic effect in the next experiment. We have corrected the description in the article to avoid misunderstanding

4. The figures and Tables are not explained in order, in the main text. We have carefully checked the whole text and corrected the issues you raised.?

5. Fig 2, chromatogram of standard is missing, explanation of different peaks are also missing

We have supplied the standard chromatogram in Figure 2, and appended the particular information of each peak, including the name of the substance and the percentage.

6. Expression of "p value" is misleading

We are sorry that we have not comprehended your meaning. The expression of "p value" in our manuscript was referred to literatures (Kim et al., 2011; Li et al., 2010).?

7. In the method section, instead of petroleum, petroleum ether would give better perception.

We are sorry about the mistake. Actually, we used petroleum ether in the experiment.

8. Tests like Indocyanine green plasma disappearance rate/ monoethylglycinexylidide test would be more sensitive tests for liver function

We selected the indicators and methods for liver function evaluation according to the published literature on animal experiments (Li et al., 2010; Mu et al., 2009; Takahashi et al., 2012; Tipoe et al., 2010). They are also well accepted as indicators in this field. Indocyanine green plasma disappearance rate/monoethylglycinexylidide test are mainly in clinical use. We will consider its application in our further studies.

9. The mechanism of ×××××× is not properly discussed.

We have endeavored to sort out the mechanism of ×××××× via further revision of the corresponding discussion. The authors would appreciate that reviewers could explicitly state the points in case of further concerns. We promise to address them immediately.

10.??Authors suggested in the limitation of the study that ×××××× is not higly pure, still it shows better activity than standard drug, not in histopathology results.

Thanks for highlighting our findings. ×××××× are promising natural products deserving further investigations. Actually we are currently optimizing the purified process to prepare high-purity ×××××× for post verification experiment.?

References:

Gala no, A., álvarez-Diduk, R., Ramírez-Silva, ., Alarcón-ángeles, G. and Rojas-Hernández, A., 2009. Role of the reacting free radicals on the antioxidantmechanism of curcumin. Chemical Physics 363, 13-23.

Kim, ., Park, J., Lee, ., Lee, ., Kwak, ., Kim, . and Lee, ., 2011. Ferulic acid protects against carbon tetrachloride-induced liver injury in mice. Toxicology 282, 104-111.

Li, ., Jiang, ., Tian, ., Qu, ., Zhu, . and Fu, ., 2010. In vitro and in vivo antifibrotic effects of rosmarinic acid on experimental liver fibrosis. Phytomedicine 17, 282-288.

Loidl-Stahlhofen, A. and Spiteller, G., 1994. Alpha-hydroxyaldehydes, products of lipid peroxidation. Biochim Biophys Acta 1211, 156-160. Mu, Y., Liu, P., Du G, Du J, Wang, G., Long, A., Wang, L. and Li, F., 2009. Action mechanism of Yi Guan Jian Decoction on CCl4 induced cirrhosis in rats. Journal of Ethnopharmacology 121, 35-42.

Qian, Y., Shang, Y., Teng, Q., Chang, J., Fan, G., Wei, X., Ran-Ran Li, Li, H., Yao, X., Dai, F. and Zhou, B., 2011. Hydroxychalcones as potent antioxidants: structure–activity relationship analysis and mechanism

considerations. Food Chemistry 126, 241-248.

Takahashi, M., Satake, N., Yamashita, H., Tamura, A., Sasaki, M., Matsui-Yuasa, I., Tabuchi, M., Akahoshi, Y., Terada, M. and Kojima-Yuasa, A., 2012. Ecklonia cava polyphenol protects the liver against ethanol-induced injury in rats. Biochim Biophys Acta,

Tipoe, ., Leung, ., Liong, ., Lau, ., Fung, . and Nanji, ., 2010. Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon tetrachloride (CCl4)-induced liver injury in mice. Toxicology 273, 45-52.

在修改稿中千万注意自己的态度,尽量保证格式的完整性,大家可以再参考其他作者的一定要编辑认为你是认认真真修改!当然我们确实也是认真在修改的。对于不能补充数据的就多引用参考文献说明自己的结论或者讨论是有依据的,往往也是可行的。

因为自己在投稿中没有经历太多的波折,所以经验和教训也没有那么深刻,只是希望对虫友们有那么一点作用。也祝福虫友们早日发表SCI,完成博士大业。

SCISSCI 投稿过程总结

SCI投稿过程总结、投稿状态解析、修稿处理、拒稿后对策及接受后总结等(一)投稿前准备工作和需要注意的事项、投稿过程相关经验总结 投稿前准备工作和需要注意的事项: 总结提示语:1)第一作者和通信作者的区别: 通信作者(Corresponding author)通常是实际统筹处理投稿和承担答复审稿意见等工作的主导者,也常是稿件所涉及研究工作的负责人。 通信作者的姓名多位列于论文作者名单的最后(使用符号来标识说明是Corresponding author),但其贡献不亚于论文的第一作者。 通讯作者往往指课题的总负责人,负责与编辑部的一切通信联系和接受读者的咨询等。 文章的成果是属于通讯作者的,说明思路是通讯作者的,而不是第一作者。 第一作者仅代表是你做的,且是最主要的参与者! 通信作者标注名称:Corresponding author,To whom correspondence should be addressed,或The person to whom inquiries regarding the paper should be addressed 若两个以上的作者在地位上是相同的,可以采取“共同第一作者”(joint first author)的署名方式,并说明These authors contributed equally to the work。 2)作者地址的标署: 尽可能地给出详细通讯地址,邮政编码。有二位或多位作者,则每一不同的地址应按之中出现的先后顺序列出,并以相应上标符号的形式列出与相应作者的关系。 如果第一作者不是通讯作者,作者应该按期刊的相关规定表达,并提前告诉编辑。期刊大部分以星号(*)、脚注或者致谢形式标注通讯联系人。

SCI英文论文审稿意见汇总

英文论文审稿意见汇总 以下12点无轻重主次之分。每一点内容由总结性标题和代表性审稿人意见构成。1、目标和结果不清晰。 It is noted that your manuscript needs careful editing by someone with expertise in technical English editing paying particular attention to English grammar, spelling, and sentence structure so that the goals and results of the study are clear to the reader. 2、未解释研究方法或解释不充分。 ◆In general, there is a lack of explanation of replicates and statistical me thods used in the study. ◆Furthermore, an explanation of why the authors did these various experiments should be provided. 3、对于研究设计的rationale: Also, there are few explanations of the rationale for the study design. 4、夸张地陈述结论/夸大成果/不严谨: The conclusions are overstated. For example, the study did not show if the side effects from initial copper burst can be avoid with the polymer formulation. 5、对hypothesis的清晰界定: A hypothesis needs to be presented。 6、对某个概念或工具使用的rationale/定义概念: What was the rationale for the film/SBF volume ratio? 7、对研究问题的定义: Try to set the problem discussed in this paper in more clear, write one section to define the problem 8、如何凸现原创性以及如何充分地写literature review: The topic is novel but the application proposed is not so novel. 9、对claim,如A>B的证明,verification: There is no experimental comparison of the algorithm with previously known work, so it is impossible to judge whether the algorithm is an improvement on previous work. :题问度谨严、10. MNQ is easier than the primitive PNQS, how to prove that. 11、格式(重视程度): ◆In addition, the list of references is not in our style. It is close but not completely correct. I have attached a pdf file with Instructions for Authors which shows examples. ◆Before submitting a revision be sure that your material is properly prepared

SCI投稿全攻略

SCI投稿过程总结、投稿状态解析、拒稿后处理对策及接受后期相关问答综合荟萃目录 (重点是一、二、四、五、六): (一)投稿前准备工作和需要注意的事项、投稿过程相关经验总结 (二)SCI期刊投稿各种状态详解及实例综合(学习各种投稿状态+投稿经历总结) (三)问答综合篇(是否催稿、如何撤稿、一稿两投及学术不端相关内容等) (四)如何处理审稿意见(回复意见、补实验、润色、重整数据、作图及调整、申辩及其他)(五)Reject 或者Reject and resubmit后的对策和处理 (六)稿件接受后期相关问题(作者信息、地址版权、单行本、彩图费、版面费、如何汇款、清样相关等) (七)进阶篇(如何选投SCI杂志、各专业方向期刊选择、SCI写作经验) (一)投稿前准备工作和需要注意的事项、投稿过程相关经验总结 1)第一作者和通信作者的区别: 通信作者(Corresponding author)通常是实际统筹处理投稿和承担答复审稿意见等工作的主导者,也常是稿件所涉及研究工作的负责人。 通信作者的姓名多位列于论文作者名单的最后(使用符号来标识说明是Corresponding author),但其贡献不亚于论文的第一作者。 通讯作者往往指课题的总负责人,负责与编辑部的一切通信联系和接受读者的咨询等。 文章的成果是属于通讯作者的,说明思路是通讯作者的,而不是第一作者。 第一作者仅代表是你做的,且是最主要的参与者! 通信作者标注名称:Corresponding author,To whom correspondence should be addressed,或The person to whom inquiries regarding the paper should be addressed.若两个以上的作者在地位上是相同的,可以采取“共同第一作者”(joint first author)的署名方式,并说明These authors contributed equally to the work。 2)作者地址的标署: 尽可能地给出详细通讯地址,邮政编码。有二位或多位作者,则每一不同的地址应按之中出现的先后顺序列出,并以相应上标符号的形式列出与相应作者的关系。 如果第一作者不是通讯作者,作者应该按期刊的相关规定表达,并提前告诉编辑。期刊大部分以星号(*)、脚注或者致谢形式标注通讯联系人。 3)挑选审稿人的几个途径: 很多SCI杂志都需要作者自己提出该篇论文的和您研究领域相关的审稿人,比较常见的是三名左右,也有的杂志要求5-8人。 介绍几个方法: ①利用SCI、SSCI、A&HCI、ISTP检索和您研究相关的科学家; ②文章中的参考文献; ③相关期刊编委或学术会议的主席、委员; ④以前发表的类似文章的审稿人; ⑤询问比较熟识的一些专业人士; ⑥交叉审稿,邀请以前的作者; ⑦若是团队序贯研究,斟酌考虑自建期刊审稿人专家库。 PS: 如果有熟悉的同领域的专家,可以推荐一两位为宜(若你全部推荐熟人也无可厚非,但编辑基本不会全部考虑,可能对你还有点特殊“眼色”了)。考虑推荐自己文章的参考文献作者较为常用,当然,如果你是负面引用的话,务必慎重了。

分享两篇SCI论文被接收心得!

分享两篇SCI论文被接收心得! 做为研究生,不可否认sci论文在大家心目的地位,三年的硕士,或者再三年的博士,我们一直开为之奋斗着,痛苦着,快乐着.而一些诸如submit,under review,reject,minor revision or major revision的字眼则时刻牵动着我们那脆弱而且不自信的心.当稿件投出以后,想必你也像我一样每天不停的刷新邮件,而最害怕的莫过于看到"i regret to have to inform you that......."这样的消息了. 回想自己的点滴,以及最近小小的成功,我觉得我有必要,也有义务向各位朋友们分享. 硕博连读的第三年,具体说来是XX年初,我的两篇sci论文先后被接收了,下面我想回忆一下两篇论文投稿以及被接收的过程.第一篇: 杂志:talanta(2.8分) received at editorial office: 18-sep-XX article revised: 15-jan-XX article accepted for publication: 18-jan-XX 专业:生物分析化学类 说起这篇文章,可是让我痛苦了一整年,实验很多,做的很辛苦,数据相对繁多,由于这是我第一篇文章,写作方面也是摸石头过河,逐句的模仿.为了写这篇文章,我仔细研读了该领域的大约100篇文献,对别人写的好的句子,类似的句子都做了标记,在写作的过程中想起要表达什么意思的时候马上随时翻阅,这样下来,每天写一小段,有时候甚至每天就写那么几小句,大约一个月后,我发现一篇包含abstract,intrduction,experiment,results and discussion初稿居然完成了.

SCIcoveringletter及投稿经验总结

Dr. XU Jianhe The State Key Laboratory of Bioreactor Engineering East China University of Science and Technology, Shanghai 200237, China Tel: +86-21-64252498; Fax: +86-21-64252250 Elsevier 投稿各种状态总结 1. Submitted to Journal当上传结束后,显示的状态是Submitted to Journal,这个状态是自然形成的无需处理。 2. With editor如果在投稿的时候没有要求选择编辑,就先到主编那,主编会分派给别的编辑。这当中就会有另两个状态: 3. Editor assigned 4. Editor Declined Invitation 如果编辑接手处理了就会邀请审稿人了。 5. Reviewer(s) invited 如果审稿人接受那就会是以下状态: 6. Under review 这应该是一个漫长的等待。当然前面各步骤也可能很慢的,要看编辑的处理情况。 如果被邀请审稿人不想审,就会decline,编辑会重新邀请别的审稿人。 7. required review completed 审稿结束,等编辑处理。 8. Decision in Process到了这一步就快要有结果了,编辑开始考虑是给修改还是直接拒,当然也有可能直接接受的,但可能性很小,呵呵。 9. Minor revision/Major revision这个时候可以稍微庆祝一下了,问题不大了,因为有修改就有可能。具体怎么改就不多说了,谦虚谨慎是不可少的。 10. Revision Submitted to Journal 又开始了一个循环。 11. Accepted如果不要再审,只是小修改,编辑看后会马上显示这个状态,但如果要再审也会有上面的部分状态。一步会比较快,但也有慢的。看杂志的。 还有个状态是Rejected。希望不要出现。 其他库的状态,基本是大同小异,供参考: In the Rapid Review? system, your manuscript has a different status assigned to it at various stages in the process. Below is a list of the status descriptions used

SCI论文投稿经验!

SCI论文投稿经验! 2009年,我代表本课题组共投递7篇SCI论文(主要是生殖和神经方向),分别投往IF2.5—10分的杂志,经历了许多坎坷。不过,现在可喜的是已经accept了5篇,均在3分左右,revised 了2篇。在修稿和投稿过程中,本人学习了不少相关知识和积累了一些经验,现与各位战友 分享,并请大家批评指正。 内容清单: 1、本人2009年SCI投稿经验总结(含SCI投稿程序) 2、本版众多投稿相关精华帖汇聚 3、众多战友的2009年投稿经历汇总 一、本人2009年SCI论文投稿步骤及其经验总结 (一)投稿程序 1、选择合适的SCI期刊-Choose a journal。结合专业知识、2008或2007年度影响因子 表和他人经验来综合选择要投递的期刊,并进入该期刊查询系统查询近年来的文章走向。 2、下载Introduction for submission。只要到每个杂志的首页,打开submit paper一栏,点击Introduction查看或下载即可。 3、稿件及其相关材料准备-Preparation:Manuscript.doc、Tables.doc、Figures.tiff(jpg 等)、Cover letter,有时还有Title page、Copyright agreement、Conflicts of interest等。 4、网上投稿-Submit a manuscript:先到每个杂志的首页,打开submit paper一栏,先 以通讯作者的身份register一个账号,然后以author login身份登录,按照提示依次完成:Select Article Type、Enter Title、Add/Edit/Remove Authors、Submit Abstract、Enter Keywords、Select Classifications、Enter Comments、Request Editor、Attach Files,最后下载pdf,查看无误后,即可到投稿主页approve submission或直接submit it。 5、不定期关注稿件状态-Status:Submit New Manuscript、Submissions Sent Back to Author、Icomplete Submissions、Sbmissions Waiting for Author's Approval、Submissions Being Processed、Submissions Needing Revision、Rvisions Sent Back to Author、Icomplete Submissions Being Revised、Risions Waiting for Author's Approval、Revisions Being Processed、Declined Revisions。 6、修回稿的投递-Submitted the revised manuscript:主要修改revised manuscript、response to the reviewers、cover letter,还有其他修改的相关材料。程序是进入投稿主页main menu,点击revise,仍然按照原先程序投递(近似于4),切记把修改的标题、摘要和回复信等内容要修改。最后上传附件时,先把留下来且未修改的材料前打钩(表示留下不变),然 后点击next,再上传已经修改的材料(主要包括revised manuscript、response to the reviewers、cover letter等),最后下载pdf,查看无误后,即可到投稿主页approve submission或直接submit it。

(完整word版)分享SCI写作经验和一些工具

分享SCI写作经验和一些工具 这是一个一年三篇IF大于7的牛人说如何做研究和写论文一、研究生必备四本俗话说好记性不如烂笔头,所以一定要首先养成做笔记的好习惯!作为研究生下面这几个本子是必不可少的:1,实验记录本(包括试验准备本),这当然首当其冲必不可少,我就不多说了;2,Idea记录本,每次看文献对自己有用的东西先记下,由此产生的idea更不能放过,这可是做研究的本钱,好记性不如烂笔头,以后翻翻会更有想法的;3,专业概念以及理论进展记录本,每个人不可能对自己领域的概念都了如指掌,初入门者更是如此,这时候小小一个本子的作用就大了;4,讲座记录本,这本本子可能有些零杂,记录听到的内容,更要记录瞬间的灵感,以及不懂的地方,不可小视!这四本是你必不可少的,不过作为我们这些非英语专业的研究生来说,还有一个应该具备的本子就是英语好句记录本。二、论文写作要点1、选题要小,开掘要深;不要题目很大,内容却很单薄。2、写作前要读好书、翻阅大量资料、注意学术积累,在这个过程中,还要注重利用网络,特别是一些专业数据库;3、“选题新、方法新、资料新”的三新原则(老板教导的);4、“新题新做”和“小题大做”;总之,一点之见即成文。三、如何撰写实验研究论文(唐朝枢)论文发表意识:基础研究成果的表达方

式;是否急于发表(创新与严谨的关系);发表的论文与学位论文的区别(反映科学事实而不是反映作者水平)论文格式:原著、快报、简报、摘要。不同于教科书、讲义,更不同于工作总结。撰写前的准备工作:复习和准备好相关文献;再次审定实验目的(学术思想,Idea);实验资料完整并再次 审核1. Introduction: 问题的提出;研究的现状及背景;以前工作基础;本工作的目的;思路(可提假说);对象;方法;结果。在…模型上,观察…指标,以探讨…(目的)。 2. M & M ⑴材料的写法和意义; 伦理. ⑵程序与指标。操作程序:能序贯,可操作性;方法:多指标方法的排序;引出参照文献简述;改良之处;哪些详或简?⑶统计学处理 3. Results ⑴指标归类描述,忌流水帐。不分析不解释,但要体现思路;⑵文字、图、表相对独立,但避免重复;⑶避免统计错误:对照,均衡,随即,重复。计量-计数、绝对值-相对值、专一指标—综合指标的转换。盲判与非盲判。技术资料直接概率法与卡方检验;多组资料与两组资料;等级相关与直线相关;多因素与单因素分析;配对资料与独立样本资料;非正态分布资料;例数不当;平行管,混合样本;突出差异(绝对值,Δ值,变化%;联合×、÷比值,分亚组等)有效位数的保留。统计学结论与专业结论。4. Discussion ⑴背景材料:展开问题的提出;有关本研究的一些基本知识内容(不要离题太远);⑵本实验结

辑思编译:SCI论文投稿步骤

辑思编译:SCI论文投稿步骤 当科研新手们写出一篇论文准备投稿SCI时,往往却为怎样遵守SCI论文的投稿步骤以及如何避免发表SCI论文的主要问题而发愁,在此小编参考多方资料特此总结出以下SCI论文投稿步骤,与您一同分享。 1、选择合适的SCI期刊-Choose a journal。结合专业知识、2018或2017年度影响因子表和他人经验来综合选择要投递的期刊,并进入该期刊查询系统查询近年来的文章走向。 2、下载Introduction for submission。只要到每个杂志的首页,打开submit paper一栏,点击Introduction查看或下载即可。 3、稿件及其相关材料准备-Preparation:Manu.doc、Tables.doc、Figures.tiff(jpg等)、Cover letter,有时还有Title page、Copyright agreement、Conflicts of interest等。 4、网上投稿-Submit a manu:先到每个杂志的首页,打开submit paper一栏,先以通讯作者的身份register一个账号,然后以author login身份登录,按照提示依次完成:Select Article Type、Enter Title、Add/Edit/Remove Authors、Submit Abstract、Enter Keywords、Select Classifications、Enter Comments、Request Editor、Attach Files,最后下载pdf,查看无误后,即可到投稿主页approve submission或直接submit it。

SCI期刊投稿经验-各种阶段状态解读及应对

SCI期刊投稿各种状态详解及实例综合(学习各种投稿状态+投稿经历总结) 1.Submitted to Journal刚提交的状态——新手请看这里!!! 一般的步骤是这样的:网上投稿-Submit a manuscript:先到每个杂志的首页,打开submit paper一栏,先以通讯作者的身份register一个账号,然后以author login身份登录,按照提示依次完成:Select Article Type、Enter Title、Add/Edit/Remove Authors、Submit Abstract、Enter Keywords、Select Classifications、Enter Comments、Request Editor、Attach Files,最后下载pdf,查看无误后,即可到投稿主页approve submission或直接submit it。 总结提示语:对于投稿之前和提交确认投稿过程,这里还需要对投稿新手强调以下几点。因为这些小问题被编辑评个低印象分不划算,被打回也浪费了时间和精力。一条条说来: 1)大多数系统是要求word投稿正文内容的,

pdf多不为接受格式。但也有很少数要求用pdf格式的,务必注意细看稿约。 2)文献格式是否按拟投杂志标准要求核准?有的投稿系统是可以直接检查的。 3)引用文献条数是否符合该杂志要求?有的杂志不特别要求,有的还是非常重视的。如我之前投shock杂志,编辑和一位审稿人都提到参考文献不要超过35条。如果你文章写完后,能够适当精简文献条数,那么,请删减几条吧。 4)很多系统要求勾选同意一些如伦理道德的声明文件 5)提交后可能会有一个小栏目提示对提交图片的质量做了初步审查(不合格的最好重新作图再上传) 6)绝大多数投稿完成后需要view submission和最后确认(approve submission)。view submission 就是要求你再整体看看投稿填写的这些资料信息+cover letter+正文+图片表格,所生成的pdf全文是否满意、合格,也是你投稿完成前最后一次检查的机会了。PS:有的新手可

我一年来的5篇SCI投稿经历和经验,经济学也有借鉴意义哦

我一年来的5篇SCI投稿经历和经验 时间过的好快,想想明年就研究生毕业了。回想这两年多的小硕生涯,感到欣慰的是,已经完成了硕士课题任务,就等着明年的答辩了。到目前为止,本人已在J Chem Phys,Int J Mass Spectrom,Chem Phys等杂志上发表了5篇SCI论文,下面就详细谈一下我的投稿经历,希望能够给大家一点帮助。 我学的是Quantum Chemistry,主要研究的是Molecular Spectroscopy。大家都知道,研一主要是上课和查文献,一般到研二才真正进入课题。记得我第一次练手是从去年9月份帮我师兄修改文章开始。花了我一个星期的时间,投稿到J Mol Struc (THEOCHEM)。一个月后收到回信,minor revision。当天revision返回后第二天中午就accepted。由于文章很短,是以communication的形式发表的。 我真正开始写文章是从今年2月份开始的。我1月31日(农历大年初六)从家里返回学校,开始整理数据,到2月底学校开学时,两篇文章已经写出来了。让老板看过后(说实在的,他都没怎么看),3月初开始投稿,一篇投到了Chem Phys上,另一篇投到了J Mol Spectrosc上。4月初收到Chem Phys的回信,也是minor revision。按照审稿人的建议修好后,4月中旬收到结果,accepted。马上打电话给老板,说CP的文章被接受了。为此还 高兴了好几天,毕竟是第一篇处女作呀,三天后收到J Mol Spectrosc的回信。Editor said: “The reviewer has made substantive criticisms and recommends that a major revision be carried out.” The reviewer pointed out many problems; finally said: “Recommendation : not suitable for publication in JMS in present form. Very heavy revision required, to be reviewed again.” 幸运的是,这个体系并不大,算起来比较快,半个月后就把所有的修改工作完成,文章也在5月初顺利地accepted。Reviewers' comments: The authors have responded to the referee's previous suggestions reasonably well and publication of the paper in JMS is now recommended. 从3月初到5月初,短短两个月的时间两篇文章发表,感觉自己很lucky,就因为这个还获得了今年的奖学金。紧接着整理出的一篇文章也在J Mol Struc (THEOCHEM)上顺利发表。有了这三篇文章之后,自己的胆子渐渐大了起来,就想发一篇上档次的文章,于是在7月底往J Chem Phys上投了第四篇文章。本以为会很快rejected,于是每天都查看状态,准备改投。Fortunately,5天之后状态变成了Securing Referee(s), 15天后改成Under Review,25天后收到回复。The first referee pointed out five main problems,and advised major revision;he said: “The calculat ions have been performed at a reasonably high level of theory to provide accurate information for spectroscopists. The paper reports key elements of the calculations but does not attempt to interpret the results to a sufficient degree.” However, the second referee said: “This paper cannot be published in JCP because it lacks the amount of new insights necessary, i.e. the interest and impact of this contribution is limited. Although some of the experimental assignments are challenged here, the discussion mainly deals with details of the theoretical results and straightforward comparisons with experimental values. Therefore, I recommend to submit this contribution in a purely theoretical journal, such as IJQC or TCA.” 好的方面是,Editor还是给了修改的机会。于是按照two referees的建议对文章进行了较大的改动,并请一位大牛帮忙修改了一下,补充了几个结论性的观点,20天后投递修改稿。这时候反而很紧张了。两个星期不到就又收到回信,看到minor revision后,仅仅是三个很小问题,心里长长出了一口气。第二天上午修回后晚上10点收到通知,accepted。立马给老板发了个短信:JCP被接受了。从submit到accepted,前后经历了59

我的第一次SCI投稿经历

第一次SCI投稿经历总结 时间已经过去了一年多,现在回首当年其SCI投稿经历,可谓是一波三折(亚洲的应该是投到亚洲这边的,但是投到了美洲那边,绕了个大圈,所以发文后很久没有消息,中间花了很长时间询问文章的下落),花费了一年半的时间,终于能得以在Ultrasonics Sonochemistry 上发表。在这里,感谢各位前辈的指导。是和你们无私奉献,把自己的投稿经历写出来,给后来人以参考,小弟终于能得以修成正果。现在,为继前辈之精神,小弟也把自己经历写出来,以供后来人参考。在科研的道路上,咱互勉!! 这是第一次投稿,参考各位前辈的格式,通过爱思唯尔(Elsevier)网站,发给Ultrasonics Sonochemistry 编辑部的介绍信。(所涉及内容咱删去,保存其骨架,见谅!!) Cover Letter Dear Editor, We are submitting a manuscript entitled “XXX” by XXX et al. for your kind consideration for publication in Ultrasonics Sonochemistry. In this manuscript, a set of XXX were used to investigate the effect of XXX such as XXX. We believe the paper may be of particular interest to the readers of your journal. We would be grateful if the manuscript could be reviewed and considered for publication in this journal. Phone calls about the paper should be

SCI期刊投稿各种状态详解及实例综合

to Journal刚提交的状态——新手请看这里!!! 一般的步骤是这样的:网上投稿-Submit a manuscript:先到每个杂志的首页,打开submit paper 一栏,先以通讯作者的身份register一个账号,然后以author login身份登录,按照提示依次完成:Select Article Type、Enter Title、Add/Edit/Remove Authors、Submit Abstract、Enter Keywords、Select Classifications、Enter Comments、Request Editor、Attach Files,最后下载pdf,查看无误后,即可到投稿主页approve submission或直接submit it。 总结提示语:对于投稿之前和提交确认投稿过程,这里还需要对投稿新手强调以下几点。因为这些小问题被编辑评个低印象分不划算,被打回也浪费了时间和精力。一条条说来: 1)大多数系统是要求word投稿正文内容的,pdf多不为接受格式。但也有很少数要求用pdf格式的,务必注意细看稿约。 2)文献格式是否按拟投杂志标准要求核准?有的投稿系统是可以直接检查的。 3)引用文献条数是否符合该杂志要求?有的杂志不特别要求,有的还是非常重视的。如我之前投shock杂志,编辑和一位审稿人都提到参考文献不要超过35条。如果你文章写完后,能够适当精简文献条数,那么,请删减几条吧。 4)很多系统要求勾选同意一些如伦理道德的声明文件 5)提交后可能会有一个小栏目提示对提交图片的质量做了初步审查(不合格的最好重新作图再上传) 6)绝大多数投稿完成后需要view submission和最后确认(approve submission)。view submission 就是要求你再整体看看投稿填写的这些资料信息+cover letter+正文+图片表格,所生成的pdf全文是否满意、合格,也是你投稿完成前最后一次检查的机会了。 PS:有的新手可能不注意这点,提交后就不管了,还开开心心以为自己投稿成功,殊不知结果邮箱里一直没有收到投稿后的邮件回执和稿号,直到最后纳闷几天了才回去看系统状态。 received by Editorial Office文章到了编辑手里了,证明投稿成功 editor 若投稿时未要求选择编辑,则先到主编处,主编会分派给副主编或者其他编辑。这当中就会有另两个状态: I)Awaiting Editor Assignment指派责任编辑 II)Editor assigned是把你的文章分给一个编辑处理了。 III)Editor Declined Invitation 如果编辑接手处理了就会邀请审稿人了。 总结提示语:一般情况下,投稿(submit)状态后一个星期内会出现编辑处理稿件(with editor)这个状态。很多老外编辑很不能理解中国人喜欢催稿,绝大多数情况下,他们不会像国内某些期刊一样能拖上一年半载再给屁大点修回意见。要适当给编辑一点时间处理,他们也很忙的。不要轻易催稿,也有人因为催稿而立马收到杯具消息——不知是编辑不耐烦了,还是一种巧合。当然,如果submit四个星期后网上投稿系统还没出现with editor状态信息,就要询问主编了,要注意委婉用语。不过要注意,也有期刊没有with editor状态。 参考链接—— 【求助】投ATS近5周了,没音讯,焦虑 【求助】小修后with editor七周,催稿成功(附催稿信) 【求助】催稿信发给谁--催稿信发送成功,稿子被拒 【求助】第一次投稿phytochemistry,revised 之后一个月了还是显示with editor 【求助】投稿一个月后under review显示的时间变了,求大侠指点怎么回事

国外著名SCI期刊论文写作总结

论文写作总结 题目: 题目应该覆盖主要目的或者信息,也应该吸引读者,不能太长。并且应该避免附标题。 摘要: 用第三人称写,说明文章目的,方法,结果和结论,不应出现“本文”,“我们”“作者”字眼,也不要有“首次”,“最后”,“简单”,“主要”和“次要”等修饰词。 摘要四要素:研究工作的目的,方法,结果,结论 引用别人的话: 单一作者时:某某(1987)提出。。。。。。;某某(1981)的研究发现。。。。。; 几个作者时:国内一些学者(某某,1997;,某某,1984;某某,1845)的研究。。。。。; 一些研究者(某某,1998主张;某某,1874)主张。。。。。 MIT 的Arthur Smith 教授他提醒我尽量不要使用被他称为“投机性”词汇的一些词,如“obviously”,“probably”,“certainly”,“undoubtedly”等。因为使用表示可能性的词汇,这说明你不能无法证明你的观点,而是在进行假设和猜测。可信度自然非常低。 引言部分: 引言部分主要回答为什么研究,介绍论文背景,相关领域研究历史与现状,本文目的意义,创新在什么地方(有待解决的问题)引言第一句号很重要,应当明确提出这篇文章的目的,并且表示目的很重要。 引言包含的要素(老外写) 1文章的目的;2对目的的证实(为什么整个工作重要);3背景,其他人已经做了的,怎样去做的,我们以前已经做的;4指导作者:作者应该在文章中看到什么文章中让人感兴趣的关键点是什么我们使用了什么,我们使用什么方法来做的本文采用的基本方法和假设5概括和总结:作者所期望的结论是什么 编辑对引言一般意见:引言是否充分反映了当前存在的问题,并阐述了该项研究的必要性 编辑部对参考文献一般意见:参考文献是否遗漏了近期重要文献 结果: 不要罗列结果,要分析,结果间要有逻辑联系。 Plant and soil杂志主编提醒注意:引言的最后以:你研究工作的目的和提出一个清楚的假设作为结尾。并且指出,事实上对。。的研究之前没有人做个并不是一个好的理由。因为你的研究在逻辑上很可能是跟随过去的研究。

SCI论文写法全攻略——不看后悔

第一部分SCI论文全攻略之选题与创新 一、先想先写最后做 1.做研究之前,必须想清楚:结果能不能发表?发表在哪里? 2.先把文章大框写好,空出数据,等做完实验填完空就可以发了;正所谓心中有沟壑! 3.在未搞清“写什么、发哪里、自己研究与同类研究有何出色之处”之前,就不要动手做! 4.继续去看文献,去想;想不清楚就做还不如不做! 5.要想这样做,就得先看文献!要知道如何把文章架起来、要知道别人是如何讨论的、要知道自己的数据是不是说明了与别人不同的事情或别人没有做过……这个过程就是阅读文献及思考的过程,这些搞清楚了,写就简单了! 6.要是先做事,做完发现别人做过,或无法用理论来解释,岂不是冤大头? 二、如何科学选题 1.课题选择和国际接轨。想在国际核心期刊发表文献,就必须了解国际研究动态,选择与国际学术研究合拍的课题。由于多方面因素的影响,我国科学研究选题与国际先进水平还有一定距离。我国一家权威科研机构不久前在国内挑选了许多前沿领域的研究课题,准备参与国际合作,但到美国后发现近三分之二的课题已经不属前沿,在美国很少有人研究。在高校,一些教师治学严谨、基础扎实,但科研成果不突出,重要原因就是不重视有关领域学术动态,不能选得合适的课题。 2.课题要有可发展性。课题可发展性对高水平论文的持续产出具有极大作用。中国科技大学范洪义另辟蹊径,发展了诺贝尔奖得主狄拉克(Dirac)奠定的量子论的符号法,系统地建立了“有序算符内的积分理论”,1998年有24篇论文被SCI收录;他对自己论文高产的解释是,研究“具有开创性,突破一点以后就可以向纵深发展,使研究工作自成系列、成面成片”。我院被SCI收录论文最多的杨新民老师从事凸性理论研究,该理论兴起于20世纪70年代,90年代进入高峰。作为新兴研究领域,该理论本身有许多尚待研究之处,同时该理论也可用来解决最优化方面的问题。反之,有人由于所接触的问题已处于该研究分支的末端,即使在该点上有所突破,也难持续发展。 3.借助工具选题:①查阅有关领域的检索工具,这些工具各高校都有;②了解SCI收录期刊所反映的科技动态,ISI期刊信息可从https://www.360docs.net/doc/30829655.html,查获,也可从SCI印刷版每期A、D分册的来源出版物目录(Lists of Source Publications)查找,还可从ISI引用期刊报告(Journal Citation Reports,简称JCR)了解期刊信息,该文献有印刷版、网络版(JCR on the Web)和光盘版(JCR on CD-ROM);③利

SCI论文投稿步骤实例讲解经验

SCI论文投稿步骤实例讲解经验 1、选择合适的SCI 期刊-Choose a journal。结合专业知识、2009 或2008 年度影响因子表和他人经验来综合选择要投递的期刊,他人的投稿经验,可以到网站: https://www.360docs.net/doc/30829655.html,/,查找相应的杂志,大多数杂志均有其他人的投稿经验,可供参考。尤其是注意审稿周期,以及投稿命中率两点,然后进入该期刊查询系统查 询近年来的文章走向。 2、下载Introduction for submission。只要到每个杂志的首页,打开submit paper 一栏,点击Introduction 查看或下载即可。 3、稿件及其相关材料准备-Preparation:Manuscript.doc、Tables.doc、Figures.tiff(jpg 等)、Cover letter,有时还有Title page、Copyright agreement、Conflicts of interest 等。 4、网上投稿-Submit a manuscript:先到每个杂志的首页,打开submit paper 一栏,先以通讯作者的身份register 一个账号,然后以author login 身份登录,按照 提示依次完成:Select Article Type、Enter Title、Add/Edit/Remove Authors、Submit Abstract、Enter Keywords、 Select Classifications、Enter Comments、Request Editor、Attach Files,最后下载pdf,查看无误后,即可到投稿主页approve submission 或直接submit it。 5、不定期关注稿件状态-Status:Submit New Manuscript、Submissions Sent Back to Author、Icomplete Submissions、Sbmissions Waiting for Author's Approval、Submissions Being Processed、Submissions Needing Revision、Rvisions Sent Back to Author、Icomplete Submissions Being Revised、Risions Waiting for Author's Approval、Revisions Being Processed、Declined Revisions。 6、修回稿的投递-Submitted the revised manuscript:主要修改revised manuscript、 response to the reviewers、cover letter,还有其他修改的相关材料。程序是进入投稿主页 main menu,点击revise,仍然按照原先程序投递(近似于4),切记把修改的标题、摘要和回复信等内容要修改。最后上传附件时,先把留下来且未修改的材料前打钩

相关主题
相关文档
最新文档